1 through 12 years:
15 kg or less: 30 mg orally once a day
through 23 kg: 45 mg orally once a day
through 40 kg: 60 mg orally once a day
kg or greater: 75 mg orally once a day
13 years or older: 75 mg orally once a day
Duration of therapy:
-After close contact with an infected individual: 10 days
-During a community outbreak of influenza: May be continued for up to 6 weeks
-Therapy should begin within 48 hours of exposure.
-The FDA has not approved dosing for patients less than 1 year of age.
(Not approved by FDA)
AAP recommendations for full-term infants:
Less than 3 months: Not recommended unless situation judged critical.
3 months to less than 1 year: 3 mg/kg orally once a day
2005: Two NASA Kennedy Space Center scientists and three faculty members from the University of Central Florida teamed up to develop NASA’s Government and Commercial Invention of the Year for 2005, the Emulsified Zero-Valent Iron (EZVI) Technology. Designed to address the need to clean up the ground of the historic Launch Complex 34 at KSC that was polluted with chlorinated solvents used to clean Apollo rocket parts, the EZVI technology provides a cost-effective and efficient cleanup solution to underground pollution that poses a contamination threat to fresh water sources in the area. This technology has potential use for the cleanup of environmental contamination at thousands of Department of Energy, Department of Defense, NASA and private industry facilities throughout the country.